{"filing":{"accession_number":"0000883984-26-000040","cik":"0000883984","ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"icui-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000040/icui-20260806.htm"},"events":[{"id":25350,"run_id":23001,"accession_number":"0000883984-26-000040","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"ICU Medical issued a press release on August 6, 2026 announcing its second quarter 2026 financial results, including GAAP revenue of $551.7 million, GAAP net income of $19.1 million ($0.76 per diluted share), and adjusted diluted EPS of $2.37. The filing also updates full-year 2026 guidance, raising GAAP net income guidance from $26-44 million to $73-83 million and adjusted EBITDA guidance from $400-430 million to $415-435 million. This is a standard quarterly earnings release with detailed financial statements and forward-looking guidance.","company_name":"ICU MEDICAL INC/DE","ticker":"ICUI","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26147,"accession_number":"0000883984-26-000040","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"ICU Medical issued a press release on August 6, 2026 announcing its second quarter 2026 financial results, including GAAP revenue of $551.7 million, GAAP net income of $19.1 million ($0.76 per diluted share), and adjusted diluted EPS of $2.37. The filing also updates full-year 2026 guidance, raising GAAP net income guidance from $26-44 million to $73-83 million and adjusted EBITDA guidance from $400-430 million to $415-435 million. This is a standard quarterly earnings release with detailed financial statements and forward-looking guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:34:02.526442+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26147,"accession_number":"0000883984-26-000040","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"ICU Medical issued a press release on August 6, 2026 announcing its second quarter 2026 financial results, including GAAP revenue of $551.7 million, GAAP net income of $19.1 million ($0.76 per diluted share), and adjusted diluted EPS of $2.37. The filing also updates full-year 2026 guidance, raising GAAP net income guidance from $26-44 million to $73-83 million and adjusted EBITDA guidance from $400-430 million to $415-435 million. This is a standard quarterly earnings release with detailed financial statements and forward-looking guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:34:02.526442+00:00","company_name":"ICU MEDICAL INC/DE","ticker":"ICUI","filing_date":"2026-08-06"}]}